down arrow

Vista Pharma.

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE427C01021
  • NSEID:
  • BSEID: 524711
INR
12.07
0.57 (4.96%)
BSENSE

Apr 11, 12:05 PM

BSE+NSE Vol: 1.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 924.99% vs 154.36% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 25.42% vs -250.74% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 0.52% vs 34.86% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 20.31% vs -537.18% in Mar 2023

Compare Profit and Loss Results of Vista Pharma.
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
10.00
9,264.00
-9,254.00
-99.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
10.00
9,264.00
-9,254.00
-99.89%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-25.00
25.00
100.00%
Raw Materials Consumed
8.00
2,933.00
-2,925.00
-99.73%
Power & Fuel Cost
0.00
70.00
-70.00
-100.00%
Employee Cost
1.00
1,982.00
-1,981.00
-99.95%
Operating Expenses
0.00
143.00
-143.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
13.00
6,939.00
-6,926.00
-99.81%
Operating Profit (PBDIT) excl Other Income
-3.00
2,325.00
-2,328.00
-100.13%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
-2.00
2,592.00
-2,594.00
-100.08%
Interest
1.00
15.00
-14.00
-93.33%
Profit before Depriciation and Tax
-4.00
2,577.00
-2,581.00
-100.16%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
-4.00
2,259.00
-2,263.00
-100.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-5.00
2,259.00
-2,264.00
-100.22%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
-4.00
1,823.00
-1,827.00
-100.22%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-6.00
7,868.00
-7,874.00
-100.08%
Profit Available for appropriations
-10.00
9,691.00
-9,701.00
-100.10%
Appropriations
-10.00
9,691.00
-9,701.00
-100.10%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.03
45.52
-46.55
-102.26%
Profit And Loss - Net Sales
Net Sales 10.29 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 924.99% vs 154.36% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -3.31 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 25.42% vs -250.74% in Mar 2023

Profit And Loss - Interest
Interest 1.22 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 0.52% vs 34.86% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -4.51 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 20.31% vs -537.18% in Mar 2023